Shingles vaccine put to the test in frail patients
NCT ID NCT07321808
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at how well the shingles vaccine works in people with weakened immune systems, such as those with cancer or autoimmune diseases. Researchers will measure immune responses and track side effects in 300 adults. The goal is to see if the vaccine can effectively prevent shingles in these vulnerable patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- recombinant zoster vaccine (RZV)
- What this could lead to
- If successful, this could show that the vaccine effectively prevents shingles in frail patients, leading to better vaccination guidelines for this group.
- What could go wrong
- This is an observational study, not a treatment trial. It may find that the vaccine works less well in some patients due to their weakened immune systems, and results may not apply to all frail populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONNECTIVE TISSUE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Policlinico San Matteo, SC Microbiologia e Virologia
RECRUITINGPavia, Pavia, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can specially trained immune cells flush out hidden HIV?
- Can we decode the different types of pain in multiple sclerosis?
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can a Tumor's DNA guide better cancer care for kids?